Search results summary
From Health Canada
Search criteria
- Status: Select all
- Company: LUNDBECK CANADA INC
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Approved | 02239606 | LUNDBECK CANADA INC | CELEXA 10 MG | Human | Yes | Prescription | 1 | CITALOPRAM (CITALOPRAM HYDROBROMIDE) | 10 MG |
Marketed | 02239607 | LUNDBECK CANADA INC | CELEXA 20 MG | Human | Yes | Prescription | 1 | CITALOPRAM (CITALOPRAM HYDROBROMIDE) | 20 MG |
Marketed | 02239608 | LUNDBECK CANADA INC | CELEXA 40 MG | Human | Yes | Prescription | 1 | CITALOPRAM (CITALOPRAM HYDROBROMIDE) | 40 MG |
Approved | 02263211 | LUNDBECK CANADA INC | CIPRALEX -5MG | Human | Yes | Prescription | 1 | ESCITALOPRAM (ESCITALOPRAM OXALATE) | 5 MG |
Marketed | 02263238 | LUNDBECK CANADA INC | CIPRALEX -10MG | Human | Yes | Prescription | 1 | ESCITALOPRAM (ESCITALOPRAM OXALATE) | 10 MG |
Approved | 02263246 | LUNDBECK CANADA INC | CIPRALEX -15MG | Human | Yes | Prescription | 1 | ESCITALOPRAM (ESCITALOPRAM OXALATE) | 15 MG |
Marketed | 02263254 | LUNDBECK CANADA INC | CIPRALEX -20MG | Human | Yes | Prescription | 1 | ESCITALOPRAM (ESCITALOPRAM OXALATE) | 20 MG |
Cancelled Post Market | 02391449 | LUNDBECK CANADA INC | CIPRALEX MELTZ | Human | Yes | Prescription | 1 | ESCITALOPRAM | 10 MG |
Cancelled Post Market | 02391457 | LUNDBECK CANADA INC | CIPRALEX MELTZ | Human | Yes | Prescription | 1 | ESCITALOPRAM | 20 MG |
Marketed | 02230406 | LUNDBECK CANADA INC | CLOPIXOL DEPOT 200MG/ML | Human | Yes | Prescription | 1 | ZUCLOPENTHIXOL DECANOATE | 200 MG / ML |
Approved | 02230407 | LUNDBECK CANADA INC | CLOPIXOL DEPOT 500MG/ML | Human | No | Prescription | 1 | ZUCLOPENTHIXOL DECANOATE | 500 MG / ML |
Marketed | 02230402 | LUNDBECK CANADA INC | CLOPIXOL TABLETS 10MG | Human | Yes | Prescription | 1 | ZUCLOPENTHIXOL (ZUCLOPENTHIXOL HYDROCHLORIDE) | 10 MG |
Marketed | 02230403 | LUNDBECK CANADA INC | CLOPIXOL TABLETS 25MG | Human | Yes | Prescription | 1 | ZUCLOPENTHIXOL (ZUCLOPENTHIXOL HYDROCHLORIDE) | 25 MG |
Cancelled Post Market | 02230404 | LUNDBECK CANADA INC | CLOPIXOL TABLETS 40MG | Human | No | Prescription | 1 | ZUCLOPENTHIXOL (ZUCLOPENTHIXOL HYDROCHLORIDE) | 40 MG |
Marketed | 02230405 | LUNDBECK CANADA INC | CLOPIXOL-ACUPHASE 50MG/ML | Human | Yes | Prescription | 1 | ZUCLOPENTHIXOL ACETATE | 50 MG / ML |
Marketed | 02260638 | LUNDBECK CANADA INC | EBIXA | Human | Yes | Prescription | 1 | MEMANTINE HYDROCHLORIDE | 10 MG |
Marketed | 02156008 | LUNDBECK CANADA INC | FLUANXOL 0.5MG - TAB | Human | Yes | Prescription | 1 | FLUPENTIXOL (FLUPENTIXOL DIHYDROCHLORIDE) | 0.5 MG |
Marketed | 02156016 | LUNDBECK CANADA INC | FLUANXOL 3MG - TAB | Human | Yes | Prescription | 1 | FLUPENTIXOL (FLUPENTIXOL DIHYDROCHLORIDE) | 3 MG |
Marketed | 02156040 | LUNDBECK CANADA INC | FLUANXOL DEPOT 10%- LIQ IM 100MG/ML | Human | Yes | Prescription | 1 | FLUPENTIXOL DECANOATE | 100 MG / ML |
Marketed | 02156032 | LUNDBECK CANADA INC | FLUANXOL DEPOT 2% -LIQ IM 20MG/ML | Human | Yes | Prescription | 1 | FLUPENTIXOL DECANOATE | 20 MG / ML |
Marketed | 02432919 | LUNDBECK CANADA INC | TRINTELLIX | Human | Yes | Prescription | 1 | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) | 5 MG |
Marketed | 02432927 | LUNDBECK CANADA INC | TRINTELLIX | Human | Yes | Prescription | 1 | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) | 10 MG |
Approved | 02432935 | LUNDBECK CANADA INC | TRINTELLIX | Human | Yes | Prescription | 1 | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) | 15 MG |
Marketed | 02432943 | LUNDBECK CANADA INC | TRINTELLIX | Human | Yes | Prescription | 1 | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) | 20 MG |
Marketed | 02510839 | LUNDBECK CANADA INC | VYEPTI | Human | Yes | Schedule D | 1 | EPTINEZUMAB | 100 MG / ML |
Marketed | 02510839 | LUNDBECK CANADA INC | VYEPTI | Human | Yes | Prescription | 1 | EPTINEZUMAB | 100 MG / ML |
Approved | 02542269 | LUNDBECK CANADA INC | VYEPTI | Human | Yes | Prescription | 1 | EPTINEZUMAB | 300 MG / 3 ML |
Approved | 02542269 | LUNDBECK CANADA INC | VYEPTI | Human | Yes | Schedule D | 1 | EPTINEZUMAB | 300 MG / 3 ML |
Application information
Related information
Contact us
Version 4.0.2